Discover the story behind steroid toxicity and the emerging new therapeutics that could surpass them in this opinion piece.
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
Light snowfall will taper off for most of the state by the afternoon, but linger longer throughout the day for southeastern Massachusetts. EAST BOSTON, Mass. — Light snowfall will taper off for most ...
A swimmer’s favorite words to hear from a coach are “Good job.” But nothing compares to hearing, “We are starting our taper.” That moment feels like the first breath after the final turn in a ...
Background We sought to identify an optimal oral corticosteroid regimen at the onset of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), which would delay time to first relapse ...
During a live event, Hannah Choe, MD, and event participants discuss steroid-dependent chronic GVHD, favoring adding therapy over increasing steroids. Chronic graft-vs-host disease (GVHD) is a cause ...
Correspondence to Dr Duvuru Geetha, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; dgeetha1{at}jhmi.edu Objectives To evaluate the efficacy and safety ...
When added to standard care, more lupus nephritis patients achieved complete remissions with obinutuzumab (Gazyva) than with placebo. Treatment was added to mycophenolate mofetil and glucocorticoids.
Construction activity will decline slowly except for data centers. The nonresidential construction sector of the economy has changed substantially in recent years. Contractors in this sector and their ...
Objective Youth with childhood-onset SLE (cSLE) have increased risk of serious infection. It is unknown how much of this risk is due to modifiable factors such as choice of immunosuppressant. We aimed ...
Background Anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) is a severe autoimmune disorder with high morbidity and mortality. Current treatments have limitations including relapse, ...
Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results